-
Signature
-
Kelly C. Simoneaux, on behalf of Richard C. Adkerson, pursuant to a power of attorney
-
Issuer symbol
-
FCX
-
Transactions as of
-
09 Feb 2026
-
Net transactions value
-
-$31,237,990
-
Form type
-
4
-
Filing time
-
11 Feb 2026, 17:46:07 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| ADKERSON RICHARD C |
Chairman of the Board, Director |
4340 E. COTTON CENTER BLVD., SUITE 110, PHOENIX |
Kelly C. Simoneaux, on behalf of Richard C. Adkerson, pursuant to a power of attorney |
11 Feb 2026 |
0001200685 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
FCX |
Common Stock |
Award |
$0 |
+27,500 |
+0.77% |
$0.000000 |
3,604,190 |
09 Feb 2026 |
Direct |
F1 |
| transaction |
FCX |
Common Stock |
Award |
$0 |
+248,125 |
+6.9% |
$0.000000 |
3,852,315 |
09 Feb 2026 |
Direct |
F2 |
| transaction |
FCX |
Common Stock |
Tax liability |
$5,773,661 |
-95,165 |
-2.5% |
$60.67 |
3,757,150 |
09 Feb 2026 |
Direct |
F3 |
| transaction |
FCX |
Common Stock |
Sale |
$15,575,107 |
-248,031 |
-6.6% |
$62.80 |
3,509,119 |
10 Feb 2026 |
Direct |
F4 |
| transaction |
FCX |
Common Stock |
Sale |
$8,576,180 |
-132,824 |
-3.8% |
$64.57 |
3,376,295 |
11 Feb 2026 |
Direct |
F5 |
| transaction |
FCX |
Common Stock |
Sale |
$1,313,042 |
-20,136 |
-0.6% |
$65.21 |
3,356,159 |
11 Feb 2026 |
Direct |
F6, F7 |
| holding |
FCX |
Common Stock |
|
|
|
|
|
192,330 |
09 Feb 2026 |
By IRA |
|
| holding |
FCX |
Common Stock |
|
|
|
|
|
1,643,102 |
09 Feb 2026 |
Through GRATs |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
In addition to the awards reported herein, on February 9, 2026, the Reporting Person also received a grant of PSUs, which will be reflected on a Form 4 if and when such units vest. Vesting of the PSUs will be determined by the Issuer's average return on investment and relative TSR over the three-year performance period ending December 31, 2028.